tradingkey.logo
tradingkey.logo

Haleon PLC

HLN
View Detailed Chart
9.740USD
+0.040+0.41%
Close 03/25, 16:00ETQuotes delayed by 15 min
44.09BMarket Cap
35.35P/E TTM

Haleon PLC

9.740
+0.040+0.41%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.41%

5 Days

-5.53%

1 Month

-6.70%

6 Months

+11.70%

Year to Date

-3.66%

1 Year

-2.99%

View Detailed Chart

TradingKey Stock Score of Haleon PLC

Currency: USD Updated: 2026-03-25

Key Insights

Haleon PLC's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 59 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 11.08.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Haleon PLC's Score

Industry at a Glance

Industry Ranking
59 / 157
Overall Ranking
164 / 4547
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Haleon PLC Highlights

StrengthsRisks
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 8.14B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 41.40%.
Undervalued
The company’s latest PE is 35.35, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 546.97M shares, decreasing 5.54% quarter-over-quarter.
Held by Mairs and Power
Star Investor Mairs and Power holds 28.72K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.10.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
11.080
Target Price
+11.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Haleon PLC News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Haleon PLC Info

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Ticker SymbolHLN
CompanyHaleon PLC
CEOMcnamara (Brian)
Websitehttps://www.haleon.com/
KeyAI